Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls

S Sheikhbahaei, RA Werner, LB Solnes… - Seminars in nuclear …, 2019 - Elsevier
The continuing adoption of prostate specific membrane antigen (PSMA)-targeted PET for
prostate cancer molecular imaging requires imagers and clinicians alike to be aware of the …

Somatostatin receptor imaging and theranostics: current practice and future prospects

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - Soc Nuclear Med
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors

TA Hope, M Allen-Auerbach, L Bodei… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …

[HTML][HTML] Prostate-specific membrane antigen reporting and data system version 2.0

RA Werner, PE Hartrampf, WP Fendler, SE Serfling… - European urology, 2023 - Elsevier
Abstract Prostate-specific Membrane Antigen Reporting and Data System (PSMA-RADS)
was introduced for standardized reporting, and PSMA-RADS version 1.0 allows …

111In-pentetreotide scintigraphy versus 68Ga-DOTATATE PET: impact on Krenning scores and effect of tumor burden

TA Hope, J Calais, L Zhang… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Eligibility for somatostatin receptor (SSTR) radionuclide therapy uses the qualitative
Krenning score based on 111In-pentetreotide planar scintigraphy as was performed in the …

Generative adversarial networks for the creation of realistic artificial brain magnetic resonance images

K Kazuhiro, RA Werner, F Toriumi, MS Javadi… - Tomography, 2018 - mdpi.com
Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic
Resonance Images Page 1 Generative Adversarial Networks for the Creation of Realistic …

[HTML][HTML] The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?

RA Werner, A Weich, M Kircher, LB Solnes… - Theranostics, 2018 - ncbi.nlm.nih.gov
More than 25 years after the first peptide receptor radionuclide therapy (PRRT), the concept
of somatostatin receptor (SSTR)-directed imaging and therapy for neuroendocrine tumors …

Diagnosis, management and theragnostic approach of gastro-entero-pancreatic neuroendocrine neoplasms

L Piscopo, E Zampella, S Pellegrino, F Volpe, C Nappi… - Cancers, 2023 - mdpi.com
Simple Summary Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) are the
most common neuroendocrine tumors, with the ability of overexpressing somatostatin …

The challenge of evaluating response to peptide receptor radionuclide therapy in gastroenteropancreatic neuroendocrine tumors: the present and the future

V Liberini, MW Huellner, S Grimaldi, M Finessi… - Diagnostics, 2020 - mdpi.com
The NETTER-1 study has proven peptide receptor radionuclide therapy (PRRT) to be one of
the most effective therapeutic options for metastatic neuroendocrine tumors (NETs) …

[HTML][HTML] Narrative review of generative adversarial networks in medical and molecular imaging

K Koshino, RA Werner, MG Pomper… - Annals of …, 2021 - ncbi.nlm.nih.gov
Recent years have witnessed a rapidly expanding use of artificial intelligence and machine
learning in medical imaging. Generative adversarial networks (GANs) are techniques to …